Agomab
Agomab develops treatments for fibrosis and organ failure, with a pipeline of clinical programs targeting tissue repair. The Belgium-based biotech has raised $326M, most recently in a Series D round in October 2024, and employs 75 people.
The growth story
Agomab grew from 24 to 75 employees between 2022 and 2026, raising $326M along the way, most recently a Series D in October 2024.
About
Agomab creates drugs that aim to reverse fibrosis and restore organ function by leveraging growth factor biology. Its pipeline targets severe fibrotic diseases and organ failure, focusing on treatments that modify disease progression rather than just manage symptoms.
The company has raised $326M, including a Series D round in late 2024, reflecting strong investor confidence in its clinical programs. With 75 employees, Agomab operates at a scale typical of mid-stage biotechs advancing multiple candidates toward clinical trials.
Founders and leadership
Agomab's largest function is research, reflecting its focus on drug development. The company is led by a team with deep expertise in growth factor biology and fibrosis, though specific leadership details are not provided.
The Agomab org chart
Tim Knotnerus (CEO) leads 43 mapped leaders with 5 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Research 14 (0% YoY), Business Development 10 (0% YoY), Healthcare Services 6 (-14% YoY), Legal 6 (+20% YoY), Information Technology 5 (0% YoY), Program and Project Management 4 (+33% YoY).
Talent flow
Nearly half of Agomab's analyzed workforce comes from Galapagos, with others joining from Johnson & Johnson Innovative Medicine and GSK. Alumni have moved to roles at Sofinnova Partners and VIB, among others.
Most common previous employers of Agomab staff: Galapagos (28), Johnson & Johnson Innovative Medicine (8), Johnson & Johnson (4), Crucell (3), GSK (3), Alfasigma (3). Former Agomab employees most often moved to Saniona (1), Sofinnova Partners (1), Turenne Groupe (1), VIB (1), Iteria Biopharma (1), Rejuvenate Biomed (1).
Alumni worth knowing
Web traffic
Traffic mix: 18% direct, 73% search, 0% social, 0% paid.
What this company is made of
Most common skills at Agomab: Drug Development (28), Biotechnology (27), Pharmaceutics (27), Project Management (24), Clinical Trials (24), Life Sciences (23), Clinical Development (20), Good Clinical Practice (GCP) (19).
Where the team actually sits
Agomab people are concentrated in Flemish Region, Belgium (25), Antwerp Metropolitan Area (6), Belgium (4), Galicia, Spain (3). 2 offices on record.
Search footprint
Agomab attracts about 30 organic search visits a month, traffic worth roughly $0K a month if bought through ads. It gained 16 ranking keywords and lost 2 in the last period.
What employees say
- Compensation
- 2.50 / 5
- Career opportunities
- 2.90 / 5
- Senior management
- 4.00 / 5
- Work-life balance
- 3.40 / 5
Frequently asked
Agomab has 75 employees as of September 2026.
Agomab has raised $326M in total, most recently a Series D round in October 2024.
Tim Knotnerus (CEO) sits at the top of Agomab's reporting structure, with 5 direct reports.
The most common previous employers of current Agomab staff are Galapagos (28 people), Johnson & Johnson Innovative Medicine (8 people), Johnson & Johnson (4 people).
Former Agomab employees most often move to Saniona (1), Sofinnova Partners (1), Turenne Groupe (1).
Agomab attracts about 30 organic search visits a month, worth roughly $0K a month in equivalent ad spend.
The most common skills among Agomab staff are Drug Development, Biotechnology, Pharmaceutics, Project Management, Clinical Trials.
Agomab staff are concentrated in Flemish Region, Belgium (25), Antwerp Metropolitan Area (6), Belgium (4).
Agomab has about 14 people in Research, up 0% over the past year, as of September 2026.
Agomab has about 10 people in Business Development, up 0% over the past year, as of September 2026.
Computed from 63 current and 29 former Agomab profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.